home / stock / ipsef / ipsef short
Short Information | Ipsen Sa Ord (OTCMKTS:IPSEF)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 8,724 |
Total Actual Volume | 9,373 |
Short Trends | |
---|---|
Cover Days | 2 |
Short Days | 18 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 436 |
Average Short Percentage | 87.34% |
Is there a IPSEF Short Squeeze or Breakout about to happen?
See the IPSEF Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
04-24-2024 | $0 | $117.6 | $0 | $0 | 62 | 62 | 100% |
04-03-2024 | $0 | $117.6 | $0 | $0 | 15 | 15 | 100% |
03-14-2024 | $117.6 | $117.6 | $117.6 | $117.6 | 100 | 100 | 100% |
03-01-2024 | $110.3565 | $110.3565 | $110.3565 | $110.3565 | 1,559 | 1,559 | 100% |
02-29-2024 | $110.5243 | $110.5243 | $110.5243 | $110.5243 | 1,054 | 1,054 | 100% |
02-21-2024 | $111.5 | $111.5 | $111.5 | $111.5 | 100 | 100 | 100% |
02-14-2024 | $0 | $113.25 | $0 | $0 | 22 | 3 | 13.64% |
02-13-2024 | $112.21 | $113.25 | $113.25 | $112.21 | 200 | 200 | 100% |
01-10-2024 | $0 | $117.25 | $0 | $0 | 1,473 | 1,473 | 100% |
01-09-2024 | $0 | $117.25 | $0 | $0 | 16 | 1 | 6.25% |
01-02-2024 | $117.25 | $117.25 | $117.25 | $117.25 | 100 | 100 | 100% |
10-26-2023 | $0 | $117.69 | $0 | $0 | 161 | 161 | 100% |
10-16-2023 | $0 | $117.69 | $0 | $0 | 1,414 | 1,414 | 100% |
09-21-2023 | $0 | $117.69 | $0 | $0 | 1 | 1 | 100% |
09-06-2023 | $0 | $117.69 | $0 | $0 | 1,190 | 1,190 | 100% |
02-23-2023 | $116 | $115 | $116 | $115 | 500 | 385 | 77% |
11-09-2022 | $0 | $88.5 | $0 | $0 | 15 | 15 | 100% |
10-13-2022 | $0 | $88.5 | $0 | $0 | 178 | 178 | 100% |
10-05-2022 | $0 | $88.5 | $0 | $0 | 1,000 | 500 | 50% |
09-08-2022 | $0 | $88.5 | $0 | $0 | 213 | 213 | 100% |
News, Short Squeeze, Breakout and More Instantly...
Ipsen Sa Ord Company Name:
IPSEF Stock Symbol:
OTCMKTS Market:
PARIS, FRANCE, 2 May 2024 - Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-driven biopharmaceutical company, announced today the appointment of Keira Driansky as EVP, President of North America, effective May 13, 2024. She will serve on the Executive Leadership Team (ELT) and report dire...
PARIS, FRANCE, 24 April 2024 - Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-care biopharmaceutical company, today presents its sales for the first quarter of 2024. Highlights Total-sales growth of 13.3% at CER 1 , or 10.9% as reported, driven by the 16.2% ...
Ipsen enters into an option agreement to receive exclusive global rights to two candidates pursued under the collaboration Following development candidate validation, Ipsen will assume responsibility for further development and commercialization, leveraging existing neuroscience expertise...